News & Updates
Filter by Specialty:
Point-of-care diagnostics feasible for COVID-19 border testing
Point-of-care (POC) diagnostic methods, such as serology or nucleic acid amplification (NAAT) tests, have high specificity and sensitivity for the coronavirus disease 2019 (COVID-19) and can be effectively deployed as border control mechanisms, according to a recent Singapore study.
Point-of-care diagnostics feasible for COVID-19 border testing
09 Mar 2022
Female sex, hypertension, number of initial symptoms tied to long COVID risk
The risk of developing long COVID is high among women, hypertensives, and those with a higher number of initial symptoms, and these associations are independent of disease severity and clinical course, a study has found.
Female sex, hypertension, number of initial symptoms tied to long COVID risk
09 Mar 2022
Post-COVID sequelae conditions identified, could help establish definition
Patients diagnosed with COVID-19 could have an increased risk of certain conditions up to 120 days post-diagnosis, a finding which could help establish the definition of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), according to a study presented at CROI 2022.
Post-COVID sequelae conditions identified, could help establish definition
08 Mar 2022
COVID-19 vaccines less effective in immunocompromised people
Immunocompromised patients, particularly those who had undergone organ transplants, show markedly lower seroconversion rates after vaccination against the coronavirus disease 2019 (COVID-19), according to a recent Singapore meta-analysis.
COVID-19 vaccines less effective in immunocompromised people
08 Mar 2022
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
The use of empiric antibiotic therapy appears to prevent neither deterioration nor death among patients with COVID-19 pneumonia, as shown in a Singapore study.
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
04 Mar 2022
Minor changes in glucose levels first week after COVID-19 vaccine
Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.
